Patent Protection and Pharmaceutical R&D Spending in Canada
After almost two decades of compulsory licensing of prescription drugs, Canada restored full patent protection in two legislative steps taken in 1987 and 1992. The paper investigates the impact of the strengthening of intellectual property rights on corporate R&D spending in the Canadian pharmaceutical industry. Interindustry comparisons of R&D spending trends within Canada, intercountry comparisons of R&D spending trends within the pharmaceutical industry, as well as trends in Canada's share of foreign R&D spending of US-owned multinationals suggest a statistically significant increase in Canadian pharmaceutical R&D spending after 1987.
Year of publication: |
1999
|
---|---|
Authors: | Pazderka, Bohumir |
Published in: |
Canadian Public Policy. - University of Toronto Press. - Vol. 25.1999, 1, p. 29-46
|
Publisher: |
University of Toronto Press |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Palda, Kristian S., (1982)
-
Muzondo, Timothy R., (1983)
-
Occupational licensing and professional incomes in Canada
Muzondo, Timothy R., (1980)
- More ...